Contact
searchSearch
HMP Global
CIO logo
CIO 2025
Current Status of Histotripsy: Liver, Renal, and Beyond
01/29/2026
Laura Simson, MA
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal Mendiratta-Lala presented an in-depth review of the current clinical status of histotripsy for the liver and emerging nonhepatic applications.
At CIO 2025, Dr Mishal...
01/29/2026
Vascular Disease Management
Interview
Radiation Therapy Alone vs Radiation Therapy Plus Radiofrequency Ablation/Vertebral Augmentation for Painful Spine Metastasis: A Phase 2 Randomized Controlled Trial
01/15/2026
Brian J. Schiro, MD
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the Best Poster Award at CIO 2025, discusses his study on radiation therapy vs radiation therapy plus radiofrequency ablation.
Brian Schiro, MD, winner of the...
01/15/2026
Vascular Disease Management
Stumetz headshot
CIO 2025
Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes
11/25/2025
Kyle S. Stumetz, DO; Laura Simson, MA
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”
Kyle S. Stumetz, winner of the...
11/25/2025
Vascular Disease Management
CIO image
CIO 2025
Y90: Year in Review
11/12/2025
Laura Simson, MA
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J. Lewandowski presented “Y90: Year in Review,” a comprehensive update on advances in yttrium-90 (Y-90) radioembolization across hepatocellular carcinoma (HCC), cholangiocarcinoma, and metastatic liver disease.
At CIO 2025, Dr Robert J....
11/12/2025
Vascular Disease Management
RGandhi
CIO 2025
Y90 Dosimetry Pre-Conference Training for Interventional Oncology in Miami Beach
09/26/2025
Ripal Gandhi, MD
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium on Clinical Interventional Oncology (CIO), Ripal Gandhi, MD, speaks about the Y90 Dosimetry Pre-Conference, an immersive workshop designed to deepen clinicians’ expertise in Y90 radioembolization dosimetry.
In advance of the 2025 Symposium...
09/26/2025
Vascular Disease Management
AJ Gunn, MD, University of Alabama at Birmingham
Videos
Percutaneous Renal Ablation
10/17/2024
Andrew J. Gunn, MD
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses percutaneous renal ablation.
AJ Gunn, MD, discusses...
10/17/2024
Vascular Disease Management
Altan Ahmed, MD, Moffitt Cancer Center
Videos
Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
10/16/2024
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses percutaneous hepatic perfusion as a treatment option for patients with metastatic uveal melanoma.
Altan Ahmed, MD, discusses...
10/16/2024
Vascular Disease Management
Nainesh Parikh, MD, Moffitt Cancer Center
Videos
Emerging Indications for Prostate Artery Embolization
10/16/2024
Nainesh Parikh
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses the emerging indications for prostate artery embolization among patients with prostate cancer.
Nainesh Parikh, MD, discusses...
10/16/2024
Vascular Disease Management
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
Oncology Drugs With an Impact on IR Procedures
10/16/2024
Nadine Abi-Jaoudeh, MD
Nadine Abi-Jaoudeh, MD, discusses the drugs that interventional radiologists should be on the lookout for when treating patients with cancer.
Nadine Abi-Jaoudeh, MD, discusses the drugs that interventional radiologists should be on the lookout for when treating patients with cancer.
Nadine Abi-Jaoudeh, MD,...
10/16/2024
Vascular Disease Management
Ripal Gandhi, MD, FSVM
Videos
Interventional Approaches for Locally Advanced Pancreatic Cancer
10/15/2024
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
Ripal Gandhi, MD, FSVM,...
10/15/2024
Vascular Disease Management
Osman Ahmed, MD, University of Chicago Medicine
Videos
Intratumor Injections in Interventional Oncology
10/15/2024
Osman Ahmed, MD
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
Osman Ahmed, MD, discusses the...
10/15/2024
Vascular Disease Management
Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center
Videos
Cryoablation For Breast Cancer: Efficacy and Techniques
10/03/2024
Yolanda Bryce, MD, RPVI
At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.
At the 2024 CIO Meeting, Yolanda Bryce, MD, discusses the use of cryoablation for patients with breast cancer.
At the 2024 CIO Meeting, Yolanda...
10/03/2024
Vascular Disease Management
Edward Kim, MD
Videos
Previewing the 2024 Symposium on Clinical Interventional Oncology Agenda
08/28/2024
Edward Kim, MD
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he is most excited about at this year’s upcoming Symposium on Clinical Interventional Oncology.
Edward Kim, MD, shares what he...
08/28/2024
Vascular Disease Management
Nadine Abi-Jaoudeh, MD, University of California, Irvine
Videos
What to Look Forward to at This Year’s Symposium on Clinical Interventional Oncology
08/28/2024
Nadine Abi-Jaoudeh, MD
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares what she is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, shares...
08/28/2024
Vascular Disease Management
Ripal Gandhi, MD, FSVM
Videos
Program Highlights at This Year’s Symposium on Clinical Interventional Oncology
08/28/2024
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal Gandhi, MD, FSVM, shares what he is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Ripal Gandhi, MD, FSVM, shares what he is most excited about at this year’s Symposium on Clinical Interventional Oncology.
Ripal Gandhi, MD, FSVM, shares...
08/28/2024
Vascular Disease Management
Conference Coverage
Treating Liver and Colorectal Metastases: A Comprehensive Overview of Recent Data
02/02/2024
Samantha Hager
Nadine Abi-Jaoudeh, MD, provides a comprehensive overview of recent study data and innovative treatment approaches for liver and colorectal metastases at the 2023 Symposium of Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, provides a comprehensive overview of recent study data and innovative treatment approaches for liver and colorectal metastases at the 2023 Symposium of Clinical Interventional Oncology.
Nadine Abi-Jaoudeh, MD, provides...
02/02/2024
Vascular Disease Management
Conference Coverage
The Latest Updates and Ongoing Controversies in HCC Treatment: A Roundtable Discussion
02/02/2024
Samantha Hager
At the 2023 Symposium on Clinical Interventional Oncology, Edward Kim, MD, led a panel discussion exploring current hot topics and ongoing controversies in HCC treatment.
At the 2023 Symposium on Clinical Interventional Oncology, Edward Kim, MD, led a panel discussion exploring current hot topics and ongoing controversies in HCC treatment.
At the 2023 Symposium on...
02/02/2024
Vascular Disease Management
Conference Coverage
Advances in Systemic Therapy for HCC
02/02/2024
Samantha Hager
Fernando De Zarraga, MD, presented an in-depth discussion highlighting significant advancements in systemic therapy for HCC at the 2023 Symposium on Clinical Interventional Oncology.
Fernando De Zarraga, MD, presented an in-depth discussion highlighting significant advancements in systemic therapy for HCC at the 2023 Symposium on Clinical Interventional Oncology.
Fernando De Zarraga, MD,...
02/02/2024
Vascular Disease Management
Dr. Michael Chuong
CIO2023 Highlights
Which Liver Patients are Best Treated with External Beam Radiation?
01/05/2024
Michael Chuong, MD
Michael Chuong, MD delivered a presentation focusing on the role of external beam radiation therapy (EBRT) in the treatment of liver cancer during a session at the 2023 Symposium on Clinical Interventional
Michael Chuong, MD delivered a presentation focusing on the role of external beam radiation therapy (EBRT) in the treatment of liver cancer during a session at the 2023 Symposium on Clinical Interventional
Michael Chuong, MD delivered a...
01/05/2024
Vascular Disease Management
Dr. Robert Suh
CIO2023 Highlights
Lung Biopsy or Ablation Related Life-Threatening Bleeding: How I Manage It
01/05/2024
Robert Suh, MD
Robert Suh, MD, presents on the critical topic of lung biopsy or ablation-related hemorrhage, providing insights into the differentiation and management of 3 distinct types of bleeds encountered in the lung and chest cavity.
Robert Suh, MD, presents on the critical topic of lung biopsy or ablation-related hemorrhage, providing insights into the differentiation and management of 3 distinct types of bleeds encountered in the lung and chest cavity.
Robert Suh, MD, presents on the...
01/05/2024
Vascular Disease Management
Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst
CIO2023 Highlights
Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst
01/05/2024
Marisabel Bolsegui, MD, MPH
Marisabel Bolsegui discusses her CIO2023 abstract, "CIO 2023-14 Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst."
Marisabel Bolsegui discusses her CIO2023 abstract, "CIO 2023-14 Not Novel, but Effective! Sclerotherapy for Aneurysmal Bone Cyst."
Marisabel Bolsegui discusses her...
01/05/2024
Vascular Disease Management
Ebstesam Nafie
CIO2023 Highlights
A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields
12/14/2023
Ebstesam Nafie
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her CIO2023 abstract, "CIO 2023-24 A Case Report of Successful Treatment of Metastatic Liposarcoma with Pulsed Electric Fields."
Ebstesam Nafie discusses her...
12/14/2023
Vascular Disease Management
The Evolving Role of Hepatic Ablation with Dr. Raul Uppot
CIO2023 Highlights
The Evolving Role of Hepatic Ablation with Dr. Raul Uppot
12/14/2023
Raul N. Uppot, MD
Raul Uppot, MD, from Massachusetts General Hospital, delivered a comprehensive presentation on the dynamic landscape of hepatic ablation during CIO 2023. 
Raul Uppot, MD, from Massachusetts General Hospital, delivered a comprehensive presentation on the dynamic landscape of hepatic ablation during CIO 2023. 
Raul Uppot, MD, from...
12/14/2023
Vascular Disease Management
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
Interview
Managing Y90 to the GI Tract with Dr. Oleksandra Kutsenko
12/08/2023
Oleksandra Kutsenko, MD
In this brief interview, Oleksandra Kutsenko, MD, at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview, Oleksandra Kutsenko, MD, at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.
In this brief interview,...
12/08/2023
Vascular Disease Management
Case Based Lung Ablation: Top 5 Clinical and Technical Pearls
CIO2023 Highlights
Case Based Lung Ablation: Top 5 Clinical and Technical Pearls
12/07/2023
Steven Yevich, MD, MPH
Steven Yevich, MD, MPH, presented, "Case-Based Lung Ablation: Top Five Clinical and Technical Pearls", a session aimed to provide essential insights into lung ablation, a rapidly growing field within interventional oncology. 
Steven Yevich, MD, MPH, presented, "Case-Based Lung Ablation: Top Five Clinical and Technical Pearls", a session aimed to provide essential insights into lung ablation, a rapidly growing field within interventional oncology. 
Steven Yevich, MD, MPH,...
12/07/2023
Vascular Disease Management
Dr. Edward Kim
CIO2023 Highlights
HCC, Flow-Diversion, and IO Outpatient Labs with Dr. Edward Kim
12/06/2023
Edward Kim, MD
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.
In this interview feature, Dr....
12/06/2023
Vascular Disease Management
Dr. Ripal Gandhi High Lung Shunts
CIO2023 Highlights
Management of High Lung Shunts for Y90
11/30/2023
Ripal T. Gandhi, MD, FSIR, FSVM
Ripal Gandhi, MD, FSVM, delivered a presentation during Session 2 at the 2023 Symposium on Clinical Interventional Oncology on the management of high lung shunts and their implications in patients undergoing certain procedures.
Ripal Gandhi, MD, FSVM, delivered a presentation during Session 2 at the 2023 Symposium on Clinical Interventional Oncology on the management of high lung shunts and their implications in patients undergoing certain procedures.
Ripal Gandhi, MD, FSVM,...
11/30/2023
Vascular Disease Management
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
CIO2023 Highlights
Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture
11/30/2023
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-30 Palliative Ablation and Kyphoplasty for a Suspected Metastatic Fracture."
Hanna Thompson discusses her...
11/30/2023
Vascular Disease Management
Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck
CIO2023 Highlights
Thyroid Ablation After Thyroid Cancer Recurrence in a Hostile Neck
11/30/2023
Hanna K. Thompson, MD
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her CIO2023 abstract, "CIO 2023-31 Thyroid Ablation after Thyroid Cancer Recurrence in a Hostile Neck ."
Hanna Thompson discusses her...
11/30/2023
Vascular Disease Management
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
CIO2023 Highlights
Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites
11/30/2023
Hanna K. Thompson, MD
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her CIO2023 abstract, "Concurrent Liver Ablation and Paracentesis in Patients with Preexisting Ascites."
Hanna Thompson discusses her...
11/30/2023
Vascular Disease Management
Dr. Steven Yevich
CIO2023 Highlights
Multidisciplinary Tumor Boards and IO Innovations with Dr. Steven Yevich
11/30/2023
Steven Yevich, MD, MPH
In this video interview, Steven Yevich, MD, MPH at MD Anderson Cancer Center, discusses the value of multidisciplinary tumor boards and the future of interventional oncology.
In this video interview, Steven Yevich, MD, MPH at MD Anderson Cancer Center, discusses the value of multidisciplinary tumor boards and the future of interventional oncology.
In this video interview, Steven...
11/30/2023
Vascular Disease Management
Dr. Oleksandra Kutsenko
CIO2023 Highlights
Air Embolism Following Lung Biopsy/Ablation and Port Placement: How I Manage It
11/17/2023
Oleksandra Kutsenko, MD
Oleksandra Kutsenko, MD of Red Rock Radiology, delivered a presentation focusing on the significant but rare complication of air embolism associated with lung biopsies and ablations.
Oleksandra Kutsenko, MD of Red Rock Radiology, delivered a presentation focusing on the significant but rare complication of air embolism associated with lung biopsies and ablations.
Oleksandra Kutsenko, MD of Red...
11/17/2023
Vascular Disease Management
Dr. Adeel Kaiser and Dr. Robert Suh
CIO2023 Highlights
Lung Metastases: Locoregional Therapy vs External Beam Radiation
11/17/2023
Steven Yevich, MD, MPH; Robert Suh, MD; Adeel Kaiser, MD
The 2023 Symposium on Clinical Interventional Oncology (CIO) featured a panel discussion on lung metastases moderated by Dr. Steven Yevich, with insights from Dr. Robert Suh and Dr. Adeel Kaiser.
The 2023 Symposium on Clinical Interventional Oncology (CIO) featured a panel discussion on lung metastases moderated by Dr. Steven Yevich, with insights from Dr. Robert Suh and Dr. Adeel Kaiser.
The 2023 Symposium on Clinical...
11/17/2023
Vascular Disease Management
Dr. Robert Suh
CIO2023 Highlights
Lung Ablation: Year in Review
11/17/2023
Robert Suh, MD
Dr. Robert Suh, MD, presented a comprehensive overview of the current state of lung ablation during CIO 2023. 
Dr. Robert Suh, MD, presented a comprehensive overview of the current state of lung ablation during CIO 2023. 
Dr. Robert Suh, MD, presented a...
11/17/2023
Vascular Disease Management
Brendan Ryu
CIO2023 Highlights
Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review
11/14/2023
Brendan Ryu, MD
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his CIO2023 abstract, "CIO 2023-23 Efficacy and Safety of Intraarterial Chemotherapy in Locally Aggressive Breast Cancers: A 10-Year Literature Review ."
Brendan Ryu discusses his...
11/14/2023
Vascular Disease Management
Ashwin Mahendra
CIO2023 Highlights
Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia
11/13/2023
Ashwin Mahendra
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his CIO2023 abstract, "CIO 2023-35 Percutaneous Ablation of Colorectal Liver Metastasis in a Patient With Hereditary Hemorrhagic Telangiectasia."
Ashwin Mahendra discusses his...
11/13/2023
Vascular Disease Management
Dr. David S. Wang
CIO Presentation
HCC: Year in Review With Dr. David S. Wang
11/09/2023
David S. Wang, MD
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang, MD, clinical associate professor, radiology at Stanford Medicine summarized key developments in the management of hepatocellular carcinoma (HCC) over the past year.
During CIO 2023, David S. Wang,...
11/09/2023
Vascular Disease Management
Faisal Al-Qawasmi
CIO2023 Highlights
Enhancing Treatment of Hepatocellular Carcinoma With Cowpea Mosaic Virus as an Adjuvant Therapy
11/01/2023
Faisal Al-Qawasmi
Faisal Al-Qawasmi discusses his CIO2023 abstract, "CIO 2023-3 Enhancing Treatment of Hepatocellular Carcinoma With Cowpea Mosaic Virus as an Adjuvant Therapy."
Faisal Al-Qawasmi discusses his CIO2023 abstract, "CIO 2023-3 Enhancing Treatment of Hepatocellular Carcinoma With Cowpea Mosaic Virus as an Adjuvant Therapy."
Faisal Al-Qawasmi discusses his...
11/01/2023
Vascular Disease Management
Dr. Ripal Gandhi HCC
Interview
Locoregional Therapies and High Lung Shunts: An HCC Highlight With Dr. Ripal Gandhi
10/25/2023
Ripal Gandhi, MD
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.
Dr. Ripal Gandhi, MD, FSVM,...
10/25/2023
Vascular Disease Management
Dr Emily Rey
CIO2022 Highlights
Increasing Cellular Yield of Pathology Samples Through a Motorized Rotating, Aspirating Device
10/27/2022
Emily Rey, DO
Emily Rey, DO, discusses her CIO2022 abstract, "CIO 2022-31 Making the Diagnosis: Increasing Cellular Yield of Pathology Samples Through a Motorized Rotating, Aspirating Device."
Emily Rey, DO, discusses her CIO2022 abstract, "CIO 2022-31 Making the Diagnosis: Increasing Cellular Yield of Pathology Samples Through a Motorized Rotating, Aspirating Device."
Emily Rey, DO, discusses her...
10/27/2022
Vascular Disease Management
Duncan
CIO2022 Highlights
Irreversible Electroporation for Recurrent Pelvic Metastases
10/27/2022
Duncan A. Stevens
Duncan A. Stevens discusses his CIO2022 abstract, "CIO 2022-20 Irreversible Electroporation for Recurrent Pelvic Metastases: Case Series and Literature Review."
Duncan A. Stevens discusses his CIO2022 abstract, "CIO 2022-20 Irreversible Electroporation for Recurrent Pelvic Metastases: Case Series and Literature Review."
Duncan A. Stevens discusses his...
10/27/2022
Vascular Disease Management
Brennan Cronquist
CIO2022 Highlights
Irreversible Electroporation vs Microwave Ablation for HCC
10/27/2022
Brennan Cronquist
B. Cronquist, 4th year medical student at the George Washington University School of Medicine and Health Sciences, discusses his CIO2022 abstract, "CIO 2022-6 Irreversible Electroporation versus Radiofrequency Ablation as a Treatment Option...
B. Cronquist, 4th year medical student at the George Washington University School of Medicine and Health Sciences, discusses his CIO2022 abstract, "CIO 2022-6 Irreversible Electroporation versus Radiofrequency Ablation as a Treatment Option...
B. Cronquist, 4th year medical...
10/27/2022
Vascular Disease Management
Brennan Cronquist
CIO2022 Highlights
Irreversible Electroporation vs Radiofrequency Ablation for HCC
10/27/2022
Brennan Cronquist
B. Cronquist, 4th year medical student at the George Washington University School of Medicine and Health Sciences, discusses his CIO2022 abstract, "CIO 2022-6 Irreversible Electroporation versus Radiofrequency Ablation as a Treatment Option...
B. Cronquist, 4th year medical student at the George Washington University School of Medicine and Health Sciences, discusses his CIO2022 abstract, "CIO 2022-6 Irreversible Electroporation versus Radiofrequency Ablation as a Treatment Option...
B. Cronquist, 4th year medical...
10/27/2022
Vascular Disease Management
Dr Edward Kim
CIO2022 Highlights
Edward Kim, MD, FSIR, Discusses the Updated Clinical and Dosimetric Recommendations for Y-90 Glass Microspheres in HCC
10/26/2022
Edward Kim, MD
Dr Edward Kim discusses his CIO2022 abstract, "Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma."
Dr Edward Kim discusses his CIO2022 abstract, "Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma."
Dr Edward Kim discusses his...
10/26/2022
Vascular Disease Management
Dr Abou-Alfa
CIO2022 Highlights
Ghassan Abou-Alfa, MD, MBA Discusses the EMERALD-3 Trial
09/30/2022
Ghassan Abou-Alfa, MD, MBA
Dr Abou-Alfa discusses his CIO2022 abstract, "Transarterial Chemoembolization ± (Tremelimumab and Durvalumab ± Lenvatinib) in Hepatocellular Carcinoma: EMERALD-3."
Dr Abou-Alfa discusses his CIO2022 abstract, "Transarterial Chemoembolization ± (Tremelimumab and Durvalumab ± Lenvatinib) in Hepatocellular Carcinoma: EMERALD-3."
Dr Abou-Alfa discusses his...
09/30/2022
Vascular Disease Management
Dr Kamel
CIO Faculty Interview
An Interview With Dr Kamel – Flow-Directed Embolization Using a Novel Microcatheter Device
02/18/2022
Ahmed Kamel Abdel Aal, MD, PhD, FSIR
Dr Ahmed Kamel, an interventional radiologist who specializes in oncology, discusses a reflux-control microcatheter with technology for flow-directed embolization.
Dr Ahmed Kamel, an interventional radiologist who specializes in oncology, discusses a reflux-control microcatheter with technology for flow-directed embolization.
Dr Ahmed Kamel, an...
02/18/2022
Vascular Disease Management
Dr Narayanan
CIO Faculty Interview
An Interview With Dr Narayanan – A Transarterial Microcatheter Device With Fluid-Barrier Technology
02/17/2022
Govindarajan Narayanan, MD
Dr Govindarajan Narayanan, an interventional radiologist who specializes in oncology, discusses a unique peripheral microcatheter with reflux-control technology.
Dr Govindarajan Narayanan, an interventional radiologist who specializes in oncology, discusses a unique peripheral microcatheter with reflux-control technology.
Dr Govindarajan Narayanan, an...
02/17/2022
Vascular Disease Management
Preconference Fundamentals
Conference Coverage
CIO 2021 Preconference Session: IO Fundamentals
02/04/2022
IO Lexicon: Level of Evidence, Clinical Trial Design, and Understanding Clinical Endpoints Robert Lewandowski, MD, FSIR, Director of Interventional Oncology at Northwestern University Feinberg School of Medicine How to Think Like an...
IO Lexicon: Level of Evidence, Clinical Trial Design, and Understanding Clinical Endpoints Robert Lewandowski, MD, FSIR, Director of Interventional Oncology at Northwestern University Feinberg School of Medicine How to Think Like an...
IO Lexicon: Level of Evidence,...
02/04/2022
Vascular Disease Management
Session 1 New
Conference Coverage
Session 1: Year in Review - HCC and Liver Metastatic Disease
02/04/2022
HCC: Year in Review Nora Tabori, MD, Chief of Interventional Radiology, MedStar Washington Hospital Center Medical Therapies for HCC: An Oncologist's Algorithm Fernando I. De Zarraga, Jr., MD, Medical...
HCC: Year in Review Nora Tabori, MD, Chief of Interventional Radiology, MedStar Washington Hospital Center Medical Therapies for HCC: An Oncologist's Algorithm Fernando I. De Zarraga, Jr., MD, Medical...
HCC: Year in Review Nora...
02/04/2022
Vascular Disease Management
Session 2 New
Conference Coverage
Session 2: Year in Review - My Approach to Liver Disease
02/01/2022
  My Approach to Metastatic Colorectal Cancer Constantinos T. Sofocleous, MD, PhD, Professor of Radiology, Weill Cornell Medical College My Approach to Cholangiocarcinoma Susan Shamimi-Noori, Assistant...
  My Approach to Metastatic Colorectal Cancer Constantinos T. Sofocleous, MD, PhD, Professor of Radiology, Weill Cornell Medical College My Approach to Cholangiocarcinoma Susan Shamimi-Noori, Assistant...
  My Approach to...
02/01/2022
Vascular Disease Management
Session 3 New
Conference Coverage
Session 3: Practical Radioembolization
01/30/2022
Year in Review in Y-90 Radioembolization: Primary Liver Cancer  Riad Salem, MD, MBA, Chief, IR, Northwestern University Feinberg School of Medicine Year in Review in Y-90 Radioembolization: Metastatic...
Year in Review in Y-90 Radioembolization: Primary Liver Cancer  Riad Salem, MD, MBA, Chief, IR, Northwestern University Feinberg School of Medicine Year in Review in Y-90 Radioembolization: Metastatic...
Year in Review in Y-90...
01/30/2022
Vascular Disease Management
Session 4 New
Conference Coverage
Session 4: Liver Therapy - Maximizing Your Technique
01/30/2022
  Drug-Eluting Bead Chemoembolization: My Top 5 Technical Pearls Ahmed K. Abdel Aal, MD, PhD, Professor and Director of Interventional Radiology, Vice Chair of Faculty Affairs, University of Texas Health Science Center at...
  Drug-Eluting Bead Chemoembolization: My Top 5 Technical Pearls Ahmed K. Abdel Aal, MD, PhD, Professor and Director of Interventional Radiology, Vice Chair of Faculty Affairs, University of Texas Health Science Center at...
  Drug-Eluting Bead...
01/30/2022
Vascular Disease Management
Session 5
Conference Coverage
Session 5: Lung and Kidney Therapies
01/28/2022
Lung Ablation: Year in Review  Robert Suh, MD, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA Best First Cases to Develop Your Practice  Alda Tam, MD, Professor, The...
Lung Ablation: Year in Review  Robert Suh, MD, Clinical Professor, Radiological Sciences, David Geffen School of Medicine at UCLA Best First Cases to Develop Your Practice  Alda Tam, MD, Professor, The...
Lung Ablation: Year in...
01/28/2022
Vascular Disease Management
Session 6
Conference Coverage
Session 6: Growth Areas in IO
01/28/2022
IR in Prostate Cancer Shivank Bhatia, MD, Professor of Interventional Radiology, University of Miami, Miami, Florida Interventional NeuroOncology: The Next Frontier Afshin Gangi, MD, Professor of Radiology, King's...
IR in Prostate Cancer Shivank Bhatia, MD, Professor of Interventional Radiology, University of Miami, Miami, Florida Interventional NeuroOncology: The Next Frontier Afshin Gangi, MD, Professor of Radiology, King's...
IR in Prostate...
01/28/2022
Vascular Disease Management
Session 7
Conference Coverage
Session 7: MSK IO Interventions
01/28/2022
Musculoskeletal Interventional Oncologic Interventions: Year in Review Steven Yevich, MD, MPH, Associate Professor, MD Anderson Cancer Center Thermal Ablation: How I Do It Ernesto Santos Martin, MD, Attending Physician,...
Musculoskeletal Interventional Oncologic Interventions: Year in Review Steven Yevich, MD, MPH, Associate Professor, MD Anderson Cancer Center Thermal Ablation: How I Do It Ernesto Santos Martin, MD, Attending Physician,...
Musculoskeletal Interventional...
01/28/2022
Vascular Disease Management
Session 8
Conference Coverage
Session 8: Extreme IO
01/28/2022
Extreme IO: Small Subcutaneous Nodule Steven Yevich, MD, MPH, Associate Professor, MD Anderson Cancer Center Extreme IO: Cervical Spine Posterior Element Brian J. Schiro, MD, Interventional Radiologist, Miami...
Extreme IO: Small Subcutaneous Nodule Steven Yevich, MD, MPH, Associate Professor, MD Anderson Cancer Center Extreme IO: Cervical Spine Posterior Element Brian J. Schiro, MD, Interventional Radiologist, Miami...
Extreme IO: Small Subcutaneous...
01/28/2022
Vascular Disease Management
Session 9
Conference Coverage
Session 9: Palliative Care - How I Do It
01/28/2022
The Role of IR in Palliative Care and Hospice  J. David Prologo, MD, FSIR, ABOM-D, Associate Professor, Emory University School of Medicine Lymphangiograms and Lymphatic Interventions Jeffrey Forris Beecham Chick,...
The Role of IR in Palliative Care and Hospice  J. David Prologo, MD, FSIR, ABOM-D, Associate Professor, Emory University School of Medicine Lymphangiograms and Lymphatic Interventions Jeffrey Forris Beecham Chick,...
The Role of IR in Palliative...
01/28/2022
Vascular Disease Management
Session 10
Conference Coverage
Session 10: SIO Session - NCCN Guidelines
01/28/2022
Where Does IO Stand in the NCCN Guidelines: HCC Nima Kokabi, MD, Assistant Professor of Interventional Radiology, Emory University School of Medicine Where Does IO Stand in the NCCN Guidelines: ICC Daniel Brown, MD,...
Where Does IO Stand in the NCCN Guidelines: HCC Nima Kokabi, MD, Assistant Professor of Interventional Radiology, Emory University School of Medicine Where Does IO Stand in the NCCN Guidelines: ICC Daniel Brown, MD,...
Where Does IO Stand in the NCCN...
01/28/2022
Vascular Disease Management
Session 11
Conference Coverage
Session 11: Outside Your IO Comfort Zone: Learning from Our Saves and Complications
01/28/2022
Data You Should Know: Most Influential Publications Over the Last Year Ziv J. Haskal, MD, University of Virginia Postembolization Surprise Nicholas Fidelman, MD, Professor of Radiology, University of California San...
Data You Should Know: Most Influential Publications Over the Last Year Ziv J. Haskal, MD, University of Virginia Postembolization Surprise Nicholas Fidelman, MD, Professor of Radiology, University of California San...
Data You Should Know: Most...
01/28/2022
Vascular Disease Management
Videos
New Y-90 Data & Evolution Towards Super-Selective Treatment
02/18/2021
Pavan Khanna, MD, MS
Pavan Khanna, MD, Chair and Medical Director of the Department of Diagnostic and Interventional Radiology at St. Joseph’s Medical Center in Stockton, California, discusses the evolution of Y-90 for the treatment of hepatocellular carcinoma...
Pavan Khanna, MD, Chair and Medical Director of the Department of Diagnostic and Interventional Radiology at St. Joseph’s Medical Center in Stockton, California, discusses the evolution of Y-90 for the treatment of hepatocellular carcinoma...
Pavan Khanna, MD, Chair and...
02/18/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Session 1: Liver Therapy State-of-the-Art
01/30/2021
CIOctober Session 1, October 6, 2020 Industry Symposium, Sponsored by Sirtex How to use SIR Spheres Y-90 resin microspheres for a Segmental Ablation in Conjunction with MIM SurePlan Liver Y-90 Voxel-Based Dosimetry Presenter: Douglas...
CIOctober Session 1, October 6, 2020 Industry Symposium, Sponsored by Sirtex How to use SIR Spheres Y-90 resin microspheres for a Segmental Ablation in Conjunction with MIM SurePlan Liver Y-90 Voxel-Based Dosimetry Presenter: Douglas...
CIOctober Session 1, October 6,...
01/30/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Session 2: Tips and Tricks to Optimizing Outcomes
01/30/2021

CIO Course Directors and Faculty

CIO Course Directors and Faculty ...
CIOctober Session 2, October 13, 2020 Industry Symposium, Sponsored by Boston Scientific Evolution of Dosimetry using Y90 Glass Microspheres Presenters: Riad Salem, MD, MBA; Shamar Young, MD; Robert Lewandowski,...
CIOctober Session 2, October 13, 2020 Industry Symposium, Sponsored by Boston Scientific Evolution of Dosimetry using Y90 Glass Microspheres Presenters: Riad Salem, MD, MBA; Shamar Young, MD; Robert Lewandowski,...
CIOctober Session 2, October 13,...
01/30/2021
Vascular Disease Management
CIOctober, Session 3
Conference Coverage
CIO 2020 Session 3: Case-Based Learning and Morbidity and Mortality
01/28/2021
CIOctober Session 3: October 20, 2020 Full Agenda and Presentation Links Industry Symposium, Sponsored by Medtronic Advancing Clinical Evidence in the Treatment of Bone Metastases: A Multidisciplinary Discussion Presenters: Jason R....
CIOctober Session 3: October 20, 2020 Full Agenda and Presentation Links Industry Symposium, Sponsored by Medtronic Advancing Clinical Evidence in the Treatment of Bone Metastases: A Multidisciplinary Discussion Presenters: Jason R....
CIOctober Session 3: October 20,...
01/28/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Session 4: SIO Session on Oligometastatic Disease — Offering Local Therapies in Systemic Disease
01/27/2021
CIOctober Session 4: SIO Session at CIO Oligometastatic Disease: Offering Local Therapies in Systemic Disease SIO Session at CIO: Oligometastatic Disease — Definitions and Rationale Presenter: Alda Tam, MD, Professor, The...
CIOctober Session 4: SIO Session at CIO Oligometastatic Disease: Offering Local Therapies in Systemic Disease SIO Session at CIO: Oligometastatic Disease — Definitions and Rationale Presenter: Alda Tam, MD, Professor, The...
CIOctober Session 4: SIO...
01/27/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Session 5: IO During COVID: A Global Perspective
01/26/2021
Session 5: IO During COVID: A Global Perspective Interventional Oncology After Pandemic in China Presenter: Gao-Jun Teng, MD, PhD, Professor of Radiology, President, Zhongda Hospital, Southeast University, Nanjing, China IO in the...
Session 5: IO During COVID: A Global Perspective Interventional Oncology After Pandemic in China Presenter: Gao-Jun Teng, MD, PhD, Professor of Radiology, President, Zhongda Hospital, Southeast University, Nanjing, China IO in the...
Session 5: IO During COVID: A...
01/26/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Bonus Content: Innovations in IO
01/25/2021
CIO 2020 Bonus Content: Innovations in IO Getting Credit for What You Do: Optimizing E & M, Telemedicine, and Procedural Coding Presenter: Brian J. Schiro, MD, Interventional Radiologist, Miami Cardiac & Vascular Institute Human...
CIO 2020 Bonus Content: Innovations in IO Getting Credit for What You Do: Optimizing E & M, Telemedicine, and Procedural Coding Presenter: Brian J. Schiro, MD, Interventional Radiologist, Miami Cardiac & Vascular Institute Human...
CIO 2020 Bonus Content:...
01/25/2021
Vascular Disease Management
Conference Coverage
CIO 2020 Bonus Content: Best Poster Video Presentations
01/25/2021
Bonus Content: CIO Best Posters Safety of Sequential Bland Embolization - PRRT in Patients With Metastatic Neuroendocrine Tumors Presenter: Dhiraj Sikaria, MD, University of Miami Single Institution Analysis of Ablations vs Partial...
Bonus Content: CIO Best Posters Safety of Sequential Bland Embolization - PRRT in Patients With Metastatic Neuroendocrine Tumors Presenter: Dhiraj Sikaria, MD, University of Miami Single Institution Analysis of Ablations vs Partial...
Bonus Content: CIO Best...
01/25/2021
Vascular Disease Management
Conference Coverage
CIO 2020: Abstract Posters
01/23/2021
CIO 2020-1  Proximal Femoral Replacement versus Internal Fixation for the Treatment of Metastatic Disease: A Comparative Analysis B. Clayton, C. A. Gusho, N. Mehta, W. Hmeidan, M. W. Colman, S. Gitelis, A. T. Blank *Young...
CIO 2020-1  Proximal Femoral Replacement versus Internal Fixation for the Treatment of Metastatic Disease: A Comparative Analysis B. Clayton, C. A. Gusho, N. Mehta, W. Hmeidan, M. W. Colman, S. Gitelis, A. T. Blank *Young...
CIO 2020-1  Proximal...
01/23/2021
Vascular Disease Management
Videos
New Data: LEGACY Study & IRs During COVID-19
12/14/2020
Osman Ahmed, MD
Osman Ahmed, MD, FCIRSE, Assistant Professor of Vascular and Interventional Radiology at University of Chicago Medicine in Chicago, Illinois, discusses the recently published LEGACY Study, which confirmed Boston Scientific’s TheraSphere™ as a...
Osman Ahmed, MD, FCIRSE, Assistant Professor of Vascular and Interventional Radiology at University of Chicago Medicine in Chicago, Illinois, discusses the recently published LEGACY Study, which confirmed Boston Scientific’s TheraSphere™ as a...
Osman Ahmed, MD, FCIRSE,...
12/14/2020
Vascular Disease Management
Videos
TriNav™ Infusion System — A User's Perspective
12/01/2020
Ripal T. Gandhi, MD, FSIR, FSVM
In this video, Dr Ripal Gandhi discusses his experience with the TriNav™ Infusion System, including challenges, benefits, effectiveness, and more. Watch this short video to learn more about this simple, trackable, and compatible technology...
In this video, Dr Ripal Gandhi discusses his experience with the TriNav™ Infusion System, including challenges, benefits, effectiveness, and more. Watch this short video to learn more about this simple, trackable, and compatible technology...
In this video, Dr Ripal Gandhi...
12/01/2020
Vascular Disease Management
Interview
CIO 2020 Best Posters: The EMERALD-1 Study
11/06/2020
Ami Peltier; Riccardo Lencioni, MD
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo Lencioni, MD, FSIR, EBIR, regarding the trial design for the EMERALD-1 study, which was recently presented at the Symposium for Clinical Interventional Oncology (CIO) and was designated as a “CIO Best...
IO Learning spoke with Riccardo...
11/06/2020
Vascular Disease Management
Interview
CIO 2020 Best Posters: Radiation Segmentectomy as Primary Therapy for HCC
11/05/2020
Ami Peltier; Seyed Ali Montazeri, MD, MPH
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary hepatocellular carcinoma. IO Learning spoke with S. Ali Montazeri, MD, MPH, who presented his research on...
There is increasing evidence to support the concept of ablative-intent radioembolization, but the literature remains sparse for solitary hepatocellular carcinoma. IO Learning spoke with S. Ali Montazeri, MD, MPH, who presented his research on...
There is increasing evidence to...
11/05/2020
Vascular Disease Management
Conference Coverage
Learn More About CIOctober 2020: Frequently Asked Questions
08/30/2020
The revamped digital CIO meeting is almost here - see our frequently asked questions below.
The revamped digital CIO meeting is almost here - see our frequently asked questions below.
The revamped digital CIO meeting...
08/30/2020
Vascular Disease Management
Interview
Current Therapies and Future Options for Breast Cancer Treatment: An Interview With Yolanda Bryce, MD
03/25/2020
Yolanda Bryce, MD, RPVI
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.  What contributes to your ability to treat breast...
Dr Bryce spoke with IO Learning about current breast cancer treatments and future options for the 1 in 8 women who will ultimately face breast cancer in their lifetime.  What contributes to your ability to treat breast...
Dr Bryce spoke with IO Learning...
03/25/2020
Vascular Disease Management
Interview
Primer on Nerve Anatomy to Avoid Complications: An Interview With Matthew Callstrom, MD, PhD
03/06/2020
Matthew Callstrom, MD, PhD
Dr. Callstrom, Professor of Radiology at Mayo Clinic College of Medicine in Rochester, Minnesota, spoke with IO Learning at the 2019 Symposium for CIO and shared his thoughts about the complications associated with ablation in various...
Dr. Callstrom, Professor of Radiology at Mayo Clinic College of Medicine in Rochester, Minnesota, spoke with IO Learning at the 2019 Symposium for CIO and shared his thoughts about the complications associated with ablation in various...
Dr. Callstrom, Professor of...
03/06/2020
Vascular Disease Management
Interview
Hepatic Embolotherapies for Metastatic Neuroendocrine Tumors: An Interview With Jonathan Strosberg, MD
02/10/2020
Jonathan Strosberg, MD
Dr Strosberg is a Senior Member at Moffitt Cancer Center in Tampa, Florida. He spoke with IO Learning at CIO 2019 about his experience with various embolization techniques and the latest data on these treatment modalities.
Dr Strosberg is a Senior Member at Moffitt Cancer Center in Tampa, Florida. He spoke with IO Learning at CIO 2019 about his experience with various embolization techniques and the latest data on these treatment modalities.
Dr Strosberg is a Senior Member...
02/10/2020
Vascular Disease Management
Interview
Radiation Segmentectomy and Radiation Lobectomy: An Interview With Siddharth Padia, MD
02/03/2020
Siddharth A. Padia, MD
Dr Padia spoke with IO Learning about his findings on making unresectable patients resectable, success in using a newer technique, and the future of tumor ablation.
Dr Padia spoke with IO Learning about his findings on making unresectable patients resectable, success in using a newer technique, and the future of tumor ablation.
Dr Padia spoke with IO Learning...
02/03/2020
Vascular Disease Management
Interview
Tips on Treating Patients in an Outpatient Setting: An Interview With Edgar St. Amour, MD
01/21/2020
Edgar St. Amour, MD
Dr. St. Amour, Interventional Radiologist at CARTI Cancer Center in Little Rock, Arkansas, spoke with IO Learning and shared his unique perspective on transitioning from a hospital setting to treating patients in an outpatient setting.
Dr. St. Amour, Interventional Radiologist at CARTI Cancer Center in Little Rock, Arkansas, spoke with IO Learning and shared his unique perspective on transitioning from a hospital setting to treating patients in an outpatient setting.
Dr. St. Amour, Interventional...
01/21/2020
Vascular Disease Management
Interview
Nerve Blocks and Neurolysis: An Interview With David Prologo, MD
10/13/2019
David Prologo, MD, presented on cryoneurolysis at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. Prologo is an interventional radiologist from Emory University in Atlanta, Georgia, and his presentation...
David Prologo, MD, presented on cryoneurolysis at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. Prologo is an interventional radiologist from Emory University in Atlanta, Georgia, and his presentation...
David Prologo, MD,...
10/13/2019
Vascular Disease Management
Interview
Renal Mass Biopsy: When Is it Justified and What do the Guidelines Say?
10/03/2019
Tim McClure, MD, presented on renal mass biopsy this year at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. McClure is Assistant Professor of Urology and Radiology at Weill Cornell Medical College in New...
Tim McClure, MD, presented on renal mass biopsy this year at the Symposium on Clinical Interventional Oncology (CIO) in Miami, Florida. Dr. McClure is Assistant Professor of Urology and Radiology at Weill Cornell Medical College in New...
Tim McClure, MD,...
10/03/2019
Vascular Disease Management
Value Proposition in IO: Selling it to Hospitals and Oncologists
10/06/2018
When talking to hospitals and oncologists about the benefits of having a full-time interventional radiology (IR) faculty, it is important to highlight the work related value units (wRVUs) that can be brought in from a clinical prospective,...
When talking to hospitals and oncologists about the benefits of having a full-time interventional radiology (IR) faculty, it is important to highlight the work related value units (wRVUs) that can be brought in from a clinical prospective,...
When talking to hospitals and...
10/06/2018
Vascular Disease Management
Red Flags and Cautions in Y90
09/12/2018
Interventional radiologists who are interested in performing Y90 should be aware of clinical red flags including bilirubin trends, potent radiosensitizers, prior biliary intervention, and the presence of ascites, according to a presentation...
Interventional radiologists who are interested in performing Y90 should be aware of clinical red flags including bilirubin trends, potent radiosensitizers, prior biliary intervention, and the presence of ascites, according to a presentation...
Interventional radiologists who...
09/12/2018
Vascular Disease Management
Interventions for Adrenal Malignancy
08/19/2018
Interventional radiologists who are interested in performing adrenal ablations would benefit from reviewing the literature and including both an endocrinologist and anesthesiologist on the treatment team, according to a presentation by Debra...
Interventional radiologists who are interested in performing adrenal ablations would benefit from reviewing the literature and including both an endocrinologist and anesthesiologist on the treatment team, according to a presentation by Debra...
Interventional radiologists who...
08/19/2018
Vascular Disease Management
The Case for Lung Ablation
07/19/2018
Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB,...
Interventional oncologists often report that they have difficulty making the case for continuing to perform lung ablation, but many clinicians are convinced that lung ablation should remain within the scope of practice. Alice Gillams, MB,...
Interventional oncologists often...
07/19/2018
Vascular Disease Management
Tips for Performing Bland Embolization
06/21/2018
Bland embolization, an interventional technique derived from the concept of dual blood supply to the liver, was the subject of a presentation at CIO 2018 by Karen Brown, MD, FSIR. Dr. Brown is an interventional radiologist at Memorial Sloane...
Bland embolization, an interventional technique derived from the concept of dual blood supply to the liver, was the subject of a presentation at CIO 2018 by Karen Brown, MD, FSIR. Dr. Brown is an interventional radiologist at Memorial Sloane...
Bland embolization, an...
06/21/2018
Vascular Disease Management
Efficacy of Feraheme as Lymphatic Contrast Agent in Prostate Cancer
04/12/2018
CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors. Authors: M.J. Dattoli, S.M. Bravo, D.M. Kaplon, M. Hayes, A. Osorio, P.M. Dycus, D. Bostwick, J.M. Kaminski Why did you...
CIO included several featured abstracts, and we had the opportunity to talk in more detail with one of the authors. Authors: M.J. Dattoli, S.M. Bravo, D.M. Kaplon, M. Hayes, A. Osorio, P.M. Dycus, D. Bostwick, J.M. Kaminski Why did you...
CIO included several featured...
04/12/2018
Vascular Disease Management
Why Biopsy Is the Key to Personalized Medicine
03/29/2018
Biopsy is the foundation of cancer care, but its importance is often understated. As the framework of precision medicine becomes more ingrained in the standard of care, interventional radiologists must remain well versed on the latest...
Biopsy is the foundation of cancer care, but its importance is often understated. As the framework of precision medicine becomes more ingrained in the standard of care, interventional radiologists must remain well versed on the latest...
Biopsy is the foundation of...
03/29/2018
Vascular Disease Management
Is Thyroid Ablation Ready for Prime Time?
03/08/2018
by Auh Whan Park, MD, and Ziv Haskal, MD University of Virginia School of Medicine, Charlottesville, Virginia Although thyroid ablation is a common procedure in many countries around the world, it is offered less frequently in North...
by Auh Whan Park, MD, and Ziv Haskal, MD University of Virginia School of Medicine, Charlottesville, Virginia Although thyroid ablation is a common procedure in many countries around the world, it is offered less frequently in North...
by Auh Whan Park, MD, and Ziv...
03/08/2018
Vascular Disease Management
Tumor Necrosis in Conventional Versus Drug-Eluting Bead Transarterial Chemoembolization for HCC
02/22/2018
CIO included several featured abstracts, and we had the opportunity to talk in more detail with the authors. Abstract authors: E. Fayazzadeh, A.H. Amer, F. Aucejo, G. McLennan What sparked your interest in comparing outcomes of conventional...
CIO included several featured abstracts, and we had the opportunity to talk in more detail with the authors. Abstract authors: E. Fayazzadeh, A.H. Amer, F. Aucejo, G. McLennan What sparked your interest in comparing outcomes of conventional...
CIO included several featured...
02/22/2018
Vascular Disease Management
CIO and Lung Ablation: A Collective Exhale of Information
02/04/2018
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused...
Morning sessions review lung ablation therapies and potential for emerging technologies. By Brenda Silva As CIO 2018 continues, early sessions on day two looked to report on existing and emerging technologies for ablation with focused...
Morning sessions review lung...
02/04/2018
Vascular Disease Management
CIO Townhall: Examining Trials, Truths, and Threats to IO
02/03/2018
By Brenda Silva The CIO Townhall session provided an assessment of the value placed on recent trials and data that may affect interventional oncology practices and procedures. The discussion served to underscore the importance of...
By Brenda Silva The CIO Townhall session provided an assessment of the value placed on recent trials and data that may affect interventional oncology practices and procedures. The discussion served to underscore the importance of...
By Brenda Silva The CIO...
02/03/2018
Vascular Disease Management
CIO 2018: Spotlight Shines on Liver Metastatic Disease Therapies
02/03/2018
By Brenda Silva As the 10th Annual Symposium on Clinical Interventional Oncology gets underway, the first session addressed the latest developments in hepatocellular carcinoma (HCC) treatments and therapy options. Course Director Shaun...
By Brenda Silva As the 10th Annual Symposium on Clinical Interventional Oncology gets underway, the first session addressed the latest developments in hepatocellular carcinoma (HCC) treatments and therapy options. Course Director Shaun...
By Brenda Silva As the 10th...
02/03/2018
Vascular Disease Management
Lung Ablation Year in Review
01/25/2018
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen...
Lung ablation is an active area of research in interventional oncology, and recently published studies have given clinicians more factors to consider when determining which patients are good candidates for the procedure. In this Q&A, Stephen...
Lung ablation is an active area...
01/25/2018
Vascular Disease Management
Advances in Renal Ablation
12/21/2017
The landscape for renal ablation is changing as new studies suggest that certain patients may have outcomes comparable to surgery. With guidelines beginning to reflect those changes, interventional oncologists should be prepared to offer...
The landscape for renal ablation is changing as new studies suggest that certain patients may have outcomes comparable to surgery. With guidelines beginning to reflect those changes, interventional oncologists should be prepared to offer...
The landscape for renal ablation...
12/21/2017
Vascular Disease Management
Musculoskeletal Interventions Can Improve Pain and Quality of Life
12/07/2017
Patients are often left with skeletal complications and debilitating pain as a result of cancer or treatment for cancer. These fractures and other complications diminish quality of life and overall survival, but practitioners of...
Patients are often left with skeletal complications and debilitating pain as a result of cancer or treatment for cancer. These fractures and other complications diminish quality of life and overall survival, but practitioners of...
Patients are often left with...
12/07/2017
Vascular Disease Management
Y-90 Treatment in Earlier-Stage Disease Shows Promise
11/16/2017
Radioembolization with yttrium 90 (Y90) has typically been used for patients in the later stages of hepatocellular carcinoma (HCC), but new data have suggested that treating patients at earlier stages might be beneficial. In this Q&A, Robert...
Radioembolization with yttrium 90 (Y90) has typically been used for patients in the later stages of hepatocellular carcinoma (HCC), but new data have suggested that treating patients at earlier stages might be beneficial. In this Q&A, Robert...
Radioembolization with yttrium...
11/16/2017
Vascular Disease Management
Strategies for Managing Hepatopulmonary Shunting
10/18/2017
Hepatopulmonary shunting is a significant concern for practitioners of interventional oncology, as excessive shunting can result in complications such as radiation pneumonitis. There are a variety of strategies for managing these shunts in...
Hepatopulmonary shunting is a significant concern for practitioners of interventional oncology, as excessive shunting can result in complications such as radiation pneumonitis. There are a variety of strategies for managing these shunts in...
Hepatopulmonary shunting is a...
10/18/2017
Vascular Disease Management
Preventing Pitfalls in Y-90 Treatment
10/04/2017
Treatment with yttrium 90 (Y90) is an integral part of the practice of interventional oncology. Practitioners experienced with these procedures, as well as those entering the field, must navigate the decision of when to recommend treatment...
Treatment with yttrium 90 (Y90) is an integral part of the practice of interventional oncology. Practitioners experienced with these procedures, as well as those entering the field, must navigate the decision of when to recommend treatment...
Treatment with yttrium 90 (Y90)...
10/04/2017
Vascular Disease Management
Liver Metastatic Disease: The Dangers of Data Misinterpretation
09/28/2017
In this Q&A, Daniel Sze, MD, PhD, discusses the results of SIRFLOX, FOXFIRE, and FOXFIRE Global trials and how continued investigations in this area, as well as in immunotherapy, may impact the field. Dr. Sze is a Professor of Radiology at...
In this Q&A, Daniel Sze, MD, PhD, discusses the results of SIRFLOX, FOXFIRE, and FOXFIRE Global trials and how continued investigations in this area, as well as in immunotherapy, may impact the field. Dr. Sze is a Professor of Radiology at...
In this Q&A, Daniel Sze, MD,...
09/28/2017
Vascular Disease Management
From FOXFIRE to the Future: What Recently Published Studies Mean for IO
09/28/2017
In this interview with Interventional Oncology 360, Daniel Brown, MD, FSIR, chief of interventional oncology at Vanderbilt University, discusses recent changes to his practice. He also comments on the results of the FOXFIRE Global study and...
In this interview with Interventional Oncology 360, Daniel Brown, MD, FSIR, chief of interventional oncology at Vanderbilt University, discusses recent changes to his practice. He also comments on the results of the FOXFIRE Global study and...
In this interview with...
09/28/2017
Vascular Disease Management
Research Roundup in Interventional Oncology
03/20/2017
Amanda Wright Harvey
Interventional oncology is a rapidly advancing field for interventional radiologists. These image-guided and minimally invasive procedures are increasing patient quality of life through easier recoveries with less burdensome procedures,...
Interventional oncology is a rapidly advancing field for interventional radiologists. These image-guided and minimally invasive procedures are increasing patient quality of life through easier recoveries with less burdensome procedures,...
Interventional oncology is a...
03/20/2017
Vascular Disease Management
Q&A With CIO Course Director Ripal Gandhi, MD
03/20/2017
Clinical Interventional Oncology Course Director Ripal Gandhi, MD, Miami Cardiac and Vascular Institute (MCVI), shared his thoughts on the 9th annual Symposium in Hollywood Florida, Feb. 4-5, 2017. Tell us about the growing importance of IO...
Clinical Interventional Oncology Course Director Ripal Gandhi, MD, Miami Cardiac and Vascular Institute (MCVI), shared his thoughts on the 9th annual Symposium in Hollywood Florida, Feb. 4-5, 2017. Tell us about the growing importance of IO...
Clinical Interventional Oncology...
03/20/2017
Vascular Disease Management
Combination Interventional Therapy for Hepatocellular Carcinoma
03/17/2017
Karen T. Brown, MD, FSIR
Many interventional oncologists are exploring combined therapies for solitary hepatocellular cancer (HCC). The outcome of combining transarterial chemoembolization (TACE) and ablation has been reported, including two randomized, controlled...
Many interventional oncologists are exploring combined therapies for solitary hepatocellular cancer (HCC). The outcome of combining transarterial chemoembolization (TACE) and ablation has been reported, including two randomized, controlled...
Many interventional oncologists...
03/17/2017
Vascular Disease Management
As Interventional Oncology Evolves, So Does CIO
03/16/2017
Shaun Samuels, MD
Interventional oncology (IO) represents the possibility of a paradigm shift in cancer therapy. Replacing surgical therapy with non-surgical options for cure, and challenging the orthodoxy of systemic chemotherapy for the control of...
Interventional oncology (IO) represents the possibility of a paradigm shift in cancer therapy. Replacing surgical therapy with non-surgical options for cure, and challenging the orthodoxy of systemic chemotherapy for the control of...
Interventional oncology (IO)...
03/16/2017
Vascular Disease Management
CIO Spotlight: Dr Tam on the Role of Biopsy in 2017
02/19/2017
Alda L. Tam, MD, FRCPC, MBA
Alda Tam, MD Dr Alda Tam presented the session Understanding the Role of Biopsy at the 2017 Clinical Interventional Oncology Symposium. In this article, Dr Tam provides the reader with a full deciphering of her presentation. Here she...
Alda Tam, MD Dr Alda Tam presented the session Understanding the Role of Biopsy at the 2017 Clinical Interventional Oncology Symposium. In this article, Dr Tam provides the reader with a full deciphering of her presentation. Here she...
Alda Tam, MD Dr Alda Tam...
02/19/2017
Vascular Disease Management

Renowned for its originality, practicality, and focus on improving patient care, CIO highlights the most viable and sought-after treatments in the rapidly expanding field of interventional oncology. This is the must-attend symposium for those looking to learn efficient, innovative applications from best-in-class, multidisciplinary experts in order to significantly improve the lives of patients with cancer.

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use